Developer of computational chemistry software used by pharmaceutical and biotechnology companies to model molecular interactions and accelerate drug discovery. The company generates revenue from its simulation platform used in research as well as from an internal pipeline of drug candidates develope...
1 member of Congress has disclosed 2 trades in Schrödinger, Inc. (SDGR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2008-12-11 | MICHAEL T. MCCAUL | buy | — |
| 2008-12-11 | MICHAEL T. MCCAUL | sell | — |